| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |